Molecule Details
| InChIKey | DGPGXHRHNRYVDH-UHFFFAOYSA-N |
|---|---|
| Compound Name | 4-(2-((5-Methyl-1-(2-naphthalenyl)-1H-pyrazol-3-yl)oxy)ethyl)morpholine |
| Canonical SMILES | Cc1cc(OCCN2CCOCC2)nn1-c1ccc2ccccc2c1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 7.12 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB16881 |
|---|---|
| Drug Name | E-52862 |
| CAS Number | 878141-96-9 |
| Groups | experimental |
| ATC Codes | nan |
| Description | nan |
Categories: Oxazines Receptors, sigma, antagonists & inhibitors
Cross-references: BindingDB: 50396352 CHEMBL2170062 ChemSpider: 28641653 PDB: 88E Wikipedia: E-52862 ZINC: ZINC000095000617